June 14, 2012 ·
Leave a comment
June 14, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a global engagement in blood disorders with a top 30 global biopharmaceutical company.
The biopharmaceutical company, part of a select group of global leaders in drug development for a product in development to treat iron overload in the body, approached Thought Leader Select for support with its launch activities across multiple global markets. To meet the strategic needs of the company’s pre-launch for a new blood disorders treatment, Thought Leader Select will deploy its in-house research group for an assessment of key opinion leaders in the area of chelation therapy.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in the following geographic areas:
- United States
- Europe
- Japan
- Pacific Rim
- Middle East
For the global assessment, the Thought Leader Select research group will identify 100 physicians appropriate for compliant engagement in support of drug development for blood disorders.
In the second phase of the assessment, Thought Leader Select’s in-house research group will engage in its exclusive, validated methodology of deep profiling, delivering objective assessments of the skills and experience of key opinion leaders across 14 areas where health care professionals define themselves as thought ... read more »
TAGS: 
advisory boards basic research biopharmaceutical biotechnology blood disorders chelation therapy clinical research clinical trials drug development drug launch iron overload key opinion leader relationships key opinion leaders KOL KOL engagement KOL identification KOL profiling KOL reserch Kristen Smithwick medical congresses medical experts Neil Mellor pharmaceutical physicians scientific journal publishing Thought Leader Select treatment guidelines
March 14, 2012 ·
Leave a comment
Industry Insights from Brian Castle
As in nearly all other aspects of life, social media is fast becoming a dominant force in the world of healthcare. Leading centers of excellence—hospitals, clinics, research foundations, and universities—are utilizing social media to educate patients about medical resources and treatments on a daily basis. Biopharmaceutical companies are using social media to promote new medications and further educate patients about other wellness resources at their disposal to help with debilitating diseases and conditions.
Physicians and other healthcare professionals, like practically every other profession, are embracing social media at unprecedented levels, engaging with each other on everything from new medical devices to tough medical cases. Due to this rise in HCP use of social media, some have begun to question the very essence of what makes a key opinion leader in the medical profession.
Some of these questioners have gone a step farther, at their ultimate peril, in misinterpreting physician involvement in spaces like Twitter, Facebook, LinkedIn and physician-only social media networks like Sermo. They incorrectly perceive that social media participation is the new thought leadership. Last year, I sat in the audience for a presentation by a leader in the pharmaceutical industry. This person posited a talking point she’d heard from an executive at a physician-only social media network: “If you’re not in their social network, you’re not ... read more »
TAGS: basic research biopharmaceutical companies biotechnology Brian Castle centers of excellence clinical research diseases Facebook global KOL HCPs health care professionals healthcare hospitals key opinion leaders KOL engagement KOL identification KOLs LinkedIn local KOL medical clinics medical conditions medical congresses medical devices medical diagnostics medical meetings medical resources medical treatment options medications national KOL patient education pharmaceuticals physician-only social networks physicians public health regional KOL research foundations scientific journal publishing Sermo social media thought leader engagement thought leader identification Thought Leader Select thought leaders thought leadership treatment guidelines Twitter universities wellness
January 12, 2012 ·
Leave a comment
By Brian Castle and Kristen Smithwick
When most people think about thought leaders in medicine, specialists in oncology, neurology, rheumatology and other therapeutic areas immediately come to mind. However, with the proliferation of illnesses and conditions ranging from diabetes and obesity to asthma, gastrointestinal diseases and psychiatric disorders, key opinion leaders in primary care and allied health professions are more important than ever.
In addition to the growing incidence of several “lifestyle” conditions, the structure of U.S. healthcare dictates that people suffering in these areas see their primary care physicians (PCPs), nurses, nurse practitioners, physician assistants, and pharmacists with much greater frequency than their specialists. As a result, more PCPs and allied health professionals are joining their specialist colleagues in all of the critical areas that define thought leadership, including publishing, basic and clinical research, clinical practice, speaking, and advocacy involvement.
Thought Leader Select has conducted multiple assessments of thought leader populations in a variety of therapeutic areas, with particular attention to the impact of PCPs, also known as general practitioners, in areas of treatment as diverse as diabetes, allergies, infectious disease, and gastrointestinal conditions. Primary care physicians, along with their nurse practitioner (NP), physician assistant (PA), and registered nurse colleagues, consistently distinguish themselves in many of the traditional areas of thought leadership once assumed to be the domain of specialists and sub-specialists.
Leaders ... read more » TAGS: allergies allied health professions. asthma clinical practice clinical research co-investigator community disease awareness events diabetes disease task force diseases gastrointestinal grand rounds HCPs Hepatitis C hepatology HIV illnesses indigent populations infectious disease irritable bowel syndrome key opinion leaders lifestyle conditions lobbying medical conferences medical congresses medical research National Cancer Institute NCI neurology nurse practitioners obesity Oncology patient advocacy patient support PCPs pharmacists physician assistants physicians primary care psychiatric registered nurses rheumatology support groups Thought Leader Select thought leaders thought leadership US healthcare
